RBC Capital analyst Ben Hendrix lowered the price target on Chemed (NYSE: CHE) to $640.00 (from $674.00) while maintaining an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE